| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2813 | 2018 |
| Predicting 15-year prostate cancer specific mortality after radical prostatectomy SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ... The Journal of urology 185 (3), 869-875, 2011 | 757 | 2011 |
| Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona The Journal of urology 172 (6 Part 1), 2227-2231, 2004 | 711 | 2004 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 467 | 2013 |
| Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR AB Rosenkrantz, S Verma, P Choyke, SC Eberhardt, SE Eggener, ... The Journal of urology 196 (6), 1613-1618, 2016 | 413 | 2016 |
| Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities SE Eggener, PT Scardino, PR Carroll, MJ Zelefsky, O Sartor, H Hricak, ... The Journal of urology 178 (6), 2260-2267, 2007 | 411 | 2007 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 403 | 2008 |
| Management of small renal masses: American Society of Clinical Oncology clinical practice guideline A Finelli, N Ismaila, B Bro, J Durack, S Eggener, A Evans, I Gill, D Graham, ... Journal of Clinical Oncology 35 (6), 668-680, 2017 | 337 | 2017 |
| Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance RK Berglund, TA Masterson, KC Vora, SE Eggener, JA Eastham, ... The Journal of urology 180 (5), 1964-1968, 2008 | 336 | 2008 |
| Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence SE Eggener, O Yossepowitch, JA Pettus, ME Snyder, RJ Motzer, P Russo Journal of clinical oncology 24 (19), 3101-3106, 2006 | 329 | 2006 |
| New and established technology in focal ablation of the prostate: a systematic review M Valerio, Y Cerantola, SE Eggener, H Lepor, TJ Polascik, A Villers, ... European urology 71 (1), 17-34, 2017 | 319 | 2017 |
| Positive surgical margins at partial nephrectomy: predictors and oncological outcomes O Yossepowitch, RH Thompson, BC Leibovich, SE Eggener, JA Pettus, ... The Journal of urology 179 (6), 2158-2163, 2008 | 319 | 2008 |
| Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score—a computer-aided … Y Peng, Y Jiang, C Yang, JB Brown, T Antic, I Sethi, C Schmid-Tannwald, ... Radiology 267 (3), 787-796, 2013 | 312 | 2013 |
| Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis A Oto, C Yang, A Kayhan, M Tretiakova, T Antic, C Schmid-Tannwald, ... American Journal of Roentgenology 197 (6), 1382-1390, 2011 | 309 | 2011 |
| Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods O Yossepowitch, SE Eggener, FJ Bianco Jr, BS Carver, A Serio, ... The Journal of urology 178 (2), 493-499, 2007 | 304 | 2007 |
| Increasing incidence of metastatic prostate cancer in the United States (2004–2013) AB Weiner, RS Matulewicz, SE Eggener, EM Schaeffer Prostate cancer and prostatic diseases 19 (4), 395-397, 2016 | 293 | 2016 |
| Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. NM Dietz, JM Rivera, SE Eggener, RT Fix, DO Warner, MJ Joyner The Journal of physiology 480 (2), 361-368, 1994 | 281 | 1994 |
| Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma JC Brien, SF Shariat, MP Herman, CK Ng, DS Scherr, B Scoll, RG Uzzo, ... The Journal of urology 184 (1), 69-73, 2010 | 270 | 2010 |
| Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma J Messer, SF Shariat, JC Brien, MP Herman, CK Ng, DS Scherr, B Scoll, ... BJU international 108 (5), 701-705, 2011 | 268 | 2011 |
| Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge, S Bott, D Bottomley, ... European urology 67 (4), 771-777, 2015 | 257 | 2015 |
